ZURICH, Sept 24 (Reuters) - The European Union has approved Novartis's Exelon skin patch to treat Alzheimer's disease, the Swiss drugmaker said on Monday. "The European Commission has approved Exelon ...

According to the World Health Organization (WHO), an estimated 50 million people are living with dementia globally. This number is projected to increase to 82 million by 2030 and over 150 million by ...

Alzheimer’s patients may soon get the first skin patch to treat the creeping brain degeneration, a novel way to deliver an older drug so that it’s easier to take and might even work a little better.

In a study aimed at finding answers for those with advanced Alzheimer’s disease, researchers at Saint Louis University are testing a new, higher dose of the Exelon (rivastigmine) patch to learn ...

WASHINGTON – Alzheimer’s patients may soon get the first skin patch to treat the creeping brain degeneration, a novel way to deliver an older drug so that it’s easier to take and might even work a ...

Where can u get generic exelon cost with insurance online My pharmacy has now given my generic exelon cost rivastigmine patches instead of Exelon patches. In the three weeks I have had them, they have ...

The Food and Drug Administration has approved a 13.3mg/24h dosage strength of the Exelon Patch for the treatment of patients with mild to moderate Alzheimer’s disease. Approval was based on a 48-week ...

In a boost for Novartis, the Food and Drug Administration today approved the first skin patch to treat mild to moderate forms of Alzheimer's disease. The patch appears to reduce some of Exelon's side ...